Abstract: Porcine pancreatic elastase (PPE) was crystallized in complex with a novel inhibitor at pH 5 and X-ray diffraction data were collected at a synchrotron source to 1.66 Å. Crystals belong to the orthorhombic space group P2 1 2 1 2 1 , with unit cell parameters a = 50.25 Å, b = 57.94 Å and c = 74.69 Å. PPE is often used as model for drug target, due to its structural homology with the important therapeutic target human leukocyte elastase (HLE). Elastase is a serine protease that belongs to the chymotrypsin family, which has the ability to degrade elastin, an important component in connective tissues. Excessive elastin proteolysis leads to a number of pathological diseases.
INTRODUCTION
Human leukocyte elastase (HLE, EC 3.4.21.37) is a serine protease released from polymorphonuclear leukocytes (neutrophils) in response to inflammatory stimuli and mediators [1] . HLE degrades very efficiently various tissue matrix proteins such as elastin and in healthy individuals its proteolytic activity is regulated by potent endogenous antiproteases such as 1 -antitrypsin and secretory leukocyte proteinase inhibitor [2] . Imbalance between HLE and its endogenous inhibitors leads to excessive elastin proteolysis and destruction of connective tissues in a number of inflammatory diseases such as pulmonary emphysema, adult respiratory distress syndrome (ARDS), chronic bronchitis, chronic obstructive pulmonary disease (COPD), pulmonary hypertension and rheumatoid arthritis [3] [4] [5] [6] , as well as in other pulmonary pathophysiological states, e.g. cystic fibrosis [7] .
The design of low molecular-weight inhibitors of elastases has received considerable attention due to their potential therapeutic usefulness [8, 9] . Understanding the nature of inhibition and structure of the ligand-enzyme complex is a fundamental step in any structure-based lead optimization project. This is particularly true for mechanism-based inhibitors that can lead to a double-hit inactivation process [10] . -Lactams (azetidin-2-ones) are potent inhibitors of a wide range of enzymes that contain serine as the catalytic residue [11] [12] [13] . Many structural and inhibition studies with -lactams have been conducted with the readily available porcine pancreatic elastase (PPE) [14, 15] . Indeed, the sequence identity between PPE and HLE is ca. 40% [16] , and despite small differences in the primary specificity pockets [1] , PPE is considered to be a good model for HLE to be used in preliminary inhibition studies.
*Address correspondence to this author at the Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa, ITQB-UNL, Av. República, Apt. 127, 2781-901 Oeiras, Portugal; E-mail: archer@itqb.unl.pt Herein we report the crystallization and preliminary X-ray diffraction analysis of PPE inactivated with the -lactam ( Fig. 1 ), which contains a potential leaving group at C-4 position of the four-membered ring. Compound JM54 (Fig. 1) is a novel potent irreversible inhibitor of PPE (k obs /[I], of 290 M -1 s -1 ) that requires only ca. 1 mol. equivalent to inactivate the enzyme [17] . We aim towards a detailed structural characterization of the molecular interactions of PPE with this potential mechanism-based inhibitor. 
MATERIALS AND METHODS

Crystallization
Elastase from porcine pancreas (E.C. 3.4.21.36) was purchased from Serva (Cat No 20929) and was used without any further purification. The protein (MW of 25.9 kDa) was dissolved in bidistilled water to a concentration of 40 mg/ml. A concentrated solution (~150 mM) of the synthesized inhibitor JM54, was freshly prepared in DMSO. JM54 was incubated with PPE for 30 minutes at room temperature (inhibitor in a 10 molar excess, final concentration of 10% DMSO). The crystallization trials were set up at 293 K using the sitting drop vapour-diffusion method, and were based on previously known crystallization conditions [18, 19] . PPE co-crystallized with the inhibitor JM54 in 200 mM sodium sulfate and 100 mM sodium acetate at pH 5.1 yielded good quality crystals. Native crystals were also grown under the same experimental conditions to test soaking procedures with the inhibitor. 
X-Ray Data Collection and Phasing
Crystals were cryoprotected with the reservoir solution supplemented with 30% glycerol and were flash cooled in liquid nitrogen (100 K). X-ray diffraction data were collected to 1.66 Å at EMBL X11 beamline at the DORIS storage ring, DESY, Hamburg (Germany), using a wavelength of 0.82 Å. A total of 136 images were collected on a MARCCD-165 mm detector with an oscillation angle of 1.5º and an exposure time of 20 s per frame. The X-ray data were integrated and scaled using MOSFLM [20] and SCALA programs [21] . Since the crystals obtained for the enzyme:inhibitor complex were isomorphous to the native ones and belonged to the same space group, the structure was solved by Fourier synthesis [18, 19] . A rigid-body refinement step was performed with Refmac [22] yielding an R-work and R-free of 27.7 and 30.5%, respectively.
RESULTS AND DISCUSSION
The crystal quality was optimized by varying the PPE concentration (10 to 40 mg/ml), and by trying different protein:reservoir volumes and ratios. The best crystals were obtained by mixing equal volumes (1-2 μl) of PPE/JM54 mixture (~40 mg/ml) and reservoir solution. The reservoir solution contained 200 mM sodium sulfate and 100 mM sodium acetate at pH 5.1. Crystals grew within 1 to 3 days to maximum dimensions of approximately 0.8 x 0.5 x 0.1 mm (Fig. 2) . X-ray diffraction data were collected at EMBL/DESY synchrotron, Hamburg to 1.66 Å (Fig. 3) . Data collection and processing statistics are given in Table 1 . Crystals belong to the orthorhombic space group P2 1 2 1 2 1 with unit cell parameters a = 50.25 Å, b = 57.94 Å and c = 74.69 Å. The calculated V M [23] is 2.1 Å 3 /Da, which corresponds to a solvent content of ~ 41% and one molecule per asymmetric unit. Crystals of native PPE [18, 19] and PPE/inhibitor complexes [24] [25] [26] grown under the same experimental conditions show similar cell parameters. The initial calculated maps showed electron density near the catalytic triad, which corresponds to the inhibitor. Model fitting and further refinement is now in progress. 
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